Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02152085 · ClinicalTrials.gov registry record · NA

Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis

A NA study, sponsored by University of Colorado, Boulder.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT02152085: Completed NA study, sponsored by University of Colorado, Boulder.

NCT02152085 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02152085, a NA study, has completed, sponsored by University of Colorado, Boulder.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the capacity of a 6-week treatment with neuromuscular electrical stimulation to improve walking in individuals whose mobility has been compromised by multiple sclerosis.

Primary Outcome

Distance walked in 6 min

Interventions

  • DEVICE Narrow pulse
  • DEVICE Wide pulse

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2014-05
Est. Completion 2017-12-31
Phase NA
University of Colorado, Boulder

69 total trials

What the finished NCT02152085 record still lists

NCT02152085 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Narrow pulse is the first listed.

NCT02152085 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02152085 about?

NCT02152085 is a clinical study titled "Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis". The purpose of this study is to investigate the capacity of a 6-week treatment with neuromuscular electrical stimulation to improve walking in individuals whose mobility has been compromised by multiple sclerosis.

What is the current status of trial NCT02152085?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2014-05. Estimated completion is 2017-12-31.

What interventions are being tested in trial NCT02152085?

The interventions under investigation include: Narrow pulse (DEVICE), Wide pulse (DEVICE).

Who is sponsoring clinical trial NCT02152085?

This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02152085's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02152085, the US trial registry maintained by the National Library of Medicine. NCT02152085 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.